Data updated: Mar 10, 2026
ERYTHROMYCIN ESTOLATE
ERYTHROMYCIN ESTOLATE
Approved 1979-06-14
6
Indications
--
Phase 3 Trials
46
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1979-06-14
- Routes
- ORAL
- Dosage Forms
- CAPSULE, SUSPENSION
ERYTHROMYCIN ESTOLATE Approval History
Loading approval history...
What ERYTHROMYCIN ESTOLATE Treats
6 FDA approvalsOriginally approved for its first indication in 1979 . Covers 6 distinct patient populations.
- Other (6)
Other
(6 approvals)- • Approved indication (Jun 1979)
- • Approved indication (Jun 1981)
- • Approved indication (Nov 1982)
- • Approved indication (Dec 1982)
- • Approved indication (Dec 1982)
- • Approved indication (Oct 1990)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
ERYTHROMYCIN ESTOLATE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.